Anne Li An anti-aging protein called SIRT1, commonly known for being activated by red wine, has been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study now reveals that it could also be targeted to rejuvenate cells in the immune system. The protein in…...
Cancer drug leads to ‘drastic decrease’ in HIV infection in lung cancer patient
Anne Li The first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans has now been revealed by researchers. They report that while treating an HIV-infected lung cancer patient with the cancer drug nivolumab, they observed a ‘drastic and persistent decrease’ in the reservoirs of…...
Genetic link found between the immune system and lymphoma
Anne Li People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports. Scientists at The Institute of Cancer Research, London, identified six new genetic changes that increase the risk of developing Hodgkin lymphoma —…...
Oral microbiota indicates link between periodontal disease, esophageal cancer
Anne Li An analysis of bacteria present in the mouth showed that some types of bacteria that lead to periodontal disease were associated with higher risk of esophageal cancer, explains Jiyoung Ahn, PhD, an associate professor and associate director for population science at the Laura and Isaac Perlmutter Center at…...
HPV vaccine is effective, safe 10 years after it’s given, study shows
Anne Li A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report. The findings support more widespread and early administration of the HPV vaccine…...
Experimental drug trial seeks to improve treatment for head and neck cancer
Anne Li A trial to test an experimental drug in patients with head and neck cancer launches in the UK, through the Combinations Alliance – a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network. Researchers want to find out whether using Astra Zeneca’s AZD1775…...